World's Best Scientists 2026 revealed!
Hani El-Gabalawy

Hani El-Gabalawy

D-Index & Metrics

Immunology

D-Index
56
Citations
13463
World Ranking
3696
National Ranking
96

Hani El-Gabalawy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hani El-Gabalawy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 180 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hani El-Gabalawy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hani El-Gabalawy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hani El-Gabalawy is affiliated with the University of Manitoba in Canada and focuses their research primarily in the field of Medicine, with particular specialization in Rheumatology. Their work extends into several related subfields including Immunology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine, and Molecular Biology.

The researcher has published extensively on topics related to autoimmune and inflammatory disorders. Key thematic areas in their research include:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Viral Infections and Immunology Research
  • Inflammasome and immune disorders
  • Autoimmune and Inflammatory Disorders Research
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Hani El-Gabalawy's scholarship is disseminated across a number of peer-reviewed journals, with frequent publications appearing in:

  • The Journal of Rheumatology
  • Arthritis Research & Therapy
  • Frontiers in Immunology
  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology

Their recent papers illustrate a focused investigation of rheumatoid arthritis and its immunological underpinnings. Selected recent publications include:

  • Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis, 2020, Science Advances
  • IgG Anti-Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross-Sectional Study Encompassing ~1,500 Samples, 2022, Arthritis & Rheumatology
  • Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention, 2023, Frontiers in Immunology
  • Association of a Serum Protein Signature With Rheumatoid Arthritis Development, 2020, Arthritis & Rheumatology
  • A bioavailable form of curcumin, in combination with vitamin-D- and omega-3-enriched diet, modifies disease onset and outcomes in a murine model of collagen-induced arthritis, 2021, Arthritis Research & Therapy

The researcher collaborates regularly with several co-authors, including:

  • Liam J. O'Neil
  • Irene Smolik (11 publications)
  • Vidyanand Anaparti (9 publications)
  • Xiaobo Meng (7 publications)
  • Carol Hitchon (7 publications)

Best Publications

  • Mortality in systemic lupus erythematosus.

    S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi

  • Oxidation in rheumatoid arthritis

    Carol A Hitchon;Hani S El-Gabalawy

  • Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.

    Veronika Groh;Anja Brühl;Hani El-Gabalawy;J. Lee Nelson

  • Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

    Raphaela Goldbach-Mansky;Jennifer Lee;Angela McCoy;Joseph Hoxworth

  • Stromal Cell-Derived Factor-1-CXC Chemokine Receptor 4 Interactions Play a Central Role in CD4+ T Cell Accumulation in Rheumatoid Arthritis Synovium

    Toshihiro Nanki;Kenji Hayashida;Kenji Hayashida;Hani S. El-Gabalawy;Sharon Suson

  • A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?

    Jessica D. Forbes;Chih-yu Chen;Natalie C. Knox;Ruth-Ann Marrie

  • Expression and function of wingless and frizzled homologs in rheumatoid arthritis

    Malini Sen;Kevin Lauterbach;Hani El-Gabalawy;Gary S. Firestein

  • An International Cohort Study of Cancer in Systemic Lupus Erythematosus

    S. Bernatsky;J. F. Boivin;L. Joseph;R. Rajan

  • In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization.

    C.D. Hoemann;H. El-Gabalawy;M.D. McKee

  • Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.

    Carol Hitchon;Keng Wong;Guoping Ma;Jennifer Reed

  • Cancer risk in systemic lupus: An updated international multi-centre cohort study

    Sasha Bernatsky;Rosalind Ramsey-Goldman;Jeremy Labrecque;Lawrence Joseph

  • Antibodies to Porphyromonas gingivalis Are Associated with Anticitrullinated Protein Antibodies in Patients with Rheumatoid Arthritis and Their Relatives

    Carol A Hitchon;Fatiha Chandad;Elizabeth D Ferucci;Annemiek Willemze

  • Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

    Cynthia S Crowson;Silvia Rollefstad;Eirik Ikdahl;George D Kitas

  • Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities

    Hani El-Gabalawy;Lyn C Guenther;Charles N Bernstein

  • Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.

    Andreea Ioan-Facsinay;Annemiek Willemze;David B. Robinson;Christine A. Peschken

  • Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE

    Kevin D. Deane;Hani El-Gabalawy

  • Low prevalence of antibodies to glucose‐6‐phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders

    Isao Matsumoto;Isao Matsumoto;David M. Lee;Raphaela Goldbach‐Mansky;Takayuki Sumida

  • Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.

    Michelle L. Harris;Erika Darrah;Gordon K. Lam;Susan J. Bartlett

  • Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

    Philip J Mease;Kathryn Hobbs;Andrew Chalmers;Hani El-Gabalawy

  • Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis

    Hervé C. Gérard;Zhao Wang;Geng Feng Wang;Hani El-Gabalawy

Frequent Co-Authors

Charles N. Bernstein
Charles N. Bernstein University of Manitoba
Tore K. Kvien
Tore K. Kvien University of Oslo
George D. Kitas
George D. Kitas Dudley Group NHS Foundation Trust
Marvin J. Fritzler
Marvin J. Fritzler University of Calgary
René E. M. Toes
René E. M. Toes Leiden University Medical Center
Raphaela Goldbach-Mansky
Raphaela Goldbach-Mansky National Institute of Allergy and Infectious Diseases
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Caroline Gordon
Caroline Gordon University of Birmingham
Graciela S. Alarcón
Graciela S. Alarcón University of Alabama at Birmingham
Robert D. Inman
Robert D. Inman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related advanced degrees can open diverse career opportunities. Many professionals in healthcare pursue online programs to enhance their credentials and specialize further. If you’re a nurse looking to advance, exploring an accelerated RN to NP programs can fast-track your career toward becoming a nurse practitioner, which often intersects with immunology in patient care and research settings.

Transitioning within nursing specialties is also common. For example, those already certified as Family Nurse Practitioners (FNPs) can consider an FNP to ACNP bridge program online to shift into acute care roles. Such programs provide focused training relevant to immunological conditions requiring acute intervention.

For those starting with little or no nursing background, there are comprehensive online RN programs for non nurses. These provide foundational skills and knowledge essential for progressing into more specialized fields like immunology.

Understanding the economic landscape can also guide your educational choices. Salary data by specialty, such as the detailed DNP salary by specialty, helps clarify the financial benefits of advancing in specific nursing roles linked to immunology.

Best Scientists Citing Hani El-Gabalawy

Trending Scientists

Recently Published Articles